Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CDC25A | P30304 | 4/20 | 0.47 |
| ▸ | CDC25B | P30305 | 2/20 | 0.47 |
| ▸ | DHCR24 | Q15392 | 1/20 | 0.36 |
| ▸ | PPM1D | O15297 | 2/20 | 0.36 |
| ▸ | SRD5A2 | P31213 | 1/20 | 0.36 |
| ▸ | GPBAR1 | Q8TDU6 | 2/20 | 0.33 |
| ▸ | AKR1B10 | O60218 | 1/20 | 0.33 |
| ▸ | AKR1B1 | P15121 | 1/20 | 0.33 |
| ▸ | EFNA1 | P20827 | 1/20 | 0.33 |
| ▸ | EPHA2 | P29317 | 1/20 | 0.33 |
| ▸ | PSEN1 | P49768 | 1/20 | 0.33 |
| ▸ | PSEN2 | P49810 | 1/20 | 0.33 |
| ▸ | APH1B | Q8WW43 | 1/20 | 0.33 |
| ▸ | NCSTN | Q92542 | 1/20 | 0.33 |
| ▸ | APH1A | Q96BI3 | 1/20 | 0.33 |
| ▸ | PSENEN | Q9NZ42 | 1/20 | 0.33 |
| ▸ | MEN1 | O00255 | 1/20 | 0.33 |
| ▸ | LMNA | P02545 | 1/20 | 0.33 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.33 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL13343106 | 1.00 | CDC25A (0.47) | CDC25ACDC25BDHCR24PPM1DSRD5A2 | |
| SCHEMBL13343110 | 1.00 | CDC25A (0.47) | CDC25ACDC25BDHCR24PPM1DSRD5A2 | |
| SCHEMBL3182269 | 1.00 | CDC25A (0.47) | CDC25ACDC25BDHCR24PPM1DSRD5A2 | |
| SCHEMBL3182273 | 1.00 | CDC25A (0.47) | CDC25ACDC25BDHCR24PPM1DSRD5A2 | |
| SCHEMBL14107824 | 1.00 | CDC25A (0.47) | CDC25ACDC25BDHCR24PPM1DSRD5A2 | |
| SCHEMBL13343108 | 1.00 | CDC25A (0.47) | CDC25ACDC25BDHCR24PPM1DSRD5A2 | |
| SCHEMBL8213600 | 1.00 | CDC25A (0.47) | CDC25ACDC25BDHCR24PPM1DSRD5A2 | |
| SCHEMBL14107823 | 1.00 | CDC25A (0.47) | CDC25ACDC25BDHCR24PPM1DSRD5A2 | |
| SCHEMBL3182280 | 1.00 | CDC25A (0.47) | CDC25ACDC25BDHCR24PPM1DSRD5A2 | |
| SCHEMBL8201371 | 0.94 | CDC25A (0.42) | CDC25ACDC25BDHCR24PPM1DSRD5A2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20080280859-A1 | GEMINI VITAMIN D3 COMPOUNDS AND METHODS OF USE THEREOF | BIOXELL S.P.A. (IT) | 2008-11-13 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20080280859-A1 | GEMINI VITAMIN D3 COMPOUNDS AND METHODS OF USE THEREOF | VDR, GC, CYP24A1 | CDC25A 2295/4885CDC25B 2421/4885DHCR24 97/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.